AAP
PRCT icon

Arax Advisory Partners’s Procept Biorobotics PRCT Stock Holding History

Arax Advisory Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
5,741
+5,701
+14,253% +$143K ﹤0.01% 2540
2026
Q1 		$1K Sell
40
-75
-65% -$2.11K ﹤0.01% 3299
2025
Q4 		$3.62K Sell
115
-94
-45% -$3.12K ﹤0.01% 3015
2025
Q3 		$7.46K Buy
+209
New +$9.54K ﹤0.01% 2723
2025
Q2 		– Sell
-38
Closed -$2.21K – 3170
2025
Q1 		$2.21K Sell
38
-4
-10% -$273 ﹤0.01% 2035
2024
Q4 		$3.38K Sell
42
-1
-2% -$85 ﹤0.01% 1872
2024
Q3 		$3.45K Hold
43
– – ﹤0.01% 1868
2024
Q2 		$2.63K Buy
+43
New +$2.56K ﹤0.01% 1871

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arax Advisory Partners's PRCT Position: Q2 2026 in Review

Arax Advisory Partners increased its Procept Biorobotics (PRCT) stake by 14,253% in Q2 2026, buying an estimated $143K and bringing the position to 5,741 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Arax Advisory Partners first reported a position in PRCT in Q2 2024 and has held it in 8 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Arax Advisory Partners held 5,741 shares of Procept Biorobotics worth $130K as of Q2 2026.
  • Arax Advisory Partners bought 5,701 Procept Biorobotics shares in Q2 2026, an estimated $143K.
  • Procept Biorobotics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2540 holding.
  • Arax Advisory Partners first reported a position in Procept Biorobotics in Q2 2024 and has held it in 8 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.